Publication Name	World Journal of Clinical Cases
Manuscript ID	63502
Country	Taiwan

Received	2021-01-29 17:17
Peer-Review Started	2021-01-29 17:25
To Make the First Decision
Return for Revision	2021-03-31 00:58
Revised	2021-04-12 14:02
Second Decision	2021-06-02 10:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-06-02 13:09
Articles in Press	2021-06-02 13:09
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-06-08 21:32
Typeset the Manuscript	2021-07-02 09:20
Publish the Manuscript Online	2021-07-21 08:24

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
Manuscript Source	Invited Manuscript
All Author List	Chih-An Shih and Wen-Chi Chen
ORCID	Author(s) ORCID Number Chih-An Shih http://orcid.org/0000-0003-0924-6544 Wen-Chi Chen http://orcid.org/0000-0002-7572-4201
Funding Agency and Grant Number
Corresponding Author	Wen-Chi Chen, MD, Chief Doctor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, No. 386 Ta-Chung 1st Rd., Kaohsiung 813, Taiwan. wcchen@vghks.gov.tw
Key Words	Hepatitis B virus; Reactivation; Chemotherapy; Immunosuppression; Prevention
Core Tip	Reactivation of hepatitis B virus (HBV) could be fatal in the patients with hepatitis B infection and chemotherapy or immunosuppressive therapy. We review the risk of HBV reactivation (HBVr), screening of HBV infection, and the strategies of prophylaxis of HBVr in patients requiring chemotherapy and immunosuppressive therapy.
Publish Date	2021-07-21 08:24
Citation	Shih CA, Chen WC. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World J Clin Cases 2021; 9(21): 5769-5781
URL	https://www.wjgnet.com/2307-8960/full/v9/i21/5769.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i21.5769

Full Article (PDF)	WJCC-9-5769.pdf
Full Article (Word)	WJCC-9-5769.docx
Manuscript File	63502-Review-FilipodiaCL .docx
Answering Reviewers	63502-Answering reviewers.pdf
Audio Core Tip	63502-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63502-Conflict-of-interest statement.pdf
Copyright License Agreement	63502-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	63502-Language certificate.pdf
Peer-review Report	63502-Peer-review(s).pdf
Scientific Misconduct Check	63502-Bing-Wang JL-1.jpg
Scientific Misconduct Check	63502-Bing-Fan JR-2.png
Scientific Misconduct Check	63502-Scientific misconduct check.pdf
Scientific Editor Work List	63502-Scientific editor work list.pdf